[1] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会.中国帕金森病的诊断标准(2016版)[J].中华神经科杂志,2016,49(4):268-271.
[2] HUGHES A J, DANIEL S E, KILFORD L, et a1. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease:a clinic-pathological study of 100 eases[J]. J Neurol Neurosurg Psychiatry,1992,55(3):181-184.
[3] WALTER U, BEHNKE S, EYDING J, et a1. Transcranial brain parenehyma sonography in movement disorders:state of the art[J]. Ultrasound Med Biol,2007,33(1):15-25.
[4] BECKER G, SEUFERT J, BOGDAHN U, et al.Degeneration of substantia nigra in chronic Parkinson’s disease visualized by transcranial color-coded real-time sonography[J]. Neurology,1995,45(1):182-184.
[5] LI D H, HE Y C, CHEN S D, et al.Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis[J]. Sci Rep,2016,(6):20863.
[6] SHAFIEESABET A, FERESHTEHNEJAD S M, LOKK J.Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson’s disease: A meta-analysis[J]. Parkinsonism Relat Disord,2017,42:1-11.
[7] 栾海辉,张鹏,甄明清.经颅超声在运动障碍性疾病诊断中的研究进展[J].医药卫生,2022,14(11):79-82.
[8] BERARDELLI A, WENNING G K, ANTONINI A, et al.EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease[J]. Eur J Neurol,2013,20:16-34.
[9] OKAWA M, MIWA H, KAJIMOTO Y, et al.Transcranial sonography of the substantia nigra in Japanese patients with Parkinson’s disease or atypical parkinsonism: clinical potential and limitations[J]. Internal medicine (Tokyo, Japan), 2007,46:1527-1531.
[10] SAKALAUSKAS A, LUKOŠEVIČIUS A, LAUČKAITE K, et al. Automated segmentation of transcranial sonographic images in the diagnostics of Parkinson’s disease[J]. Ultrasonics,2013,53:111-121.
[11] PAULY O, AHMADI S-A, PLATE A, et al.Detection of substantia nigra echogenicities in 3D transcranial ultrasound for early diagnosis of Parkinson’s disease[J]. Med Image Comput Comput Assist Interv,2012,15: 443-450.
[12] AHMADI S-A, BAUST M, KARAMALIS A, et al.Midbrain segmentation in transcranial 3D ultrasound for Parkinson diagnosis[J]. Med Image Comput Comput Assist Interv, 2011,14:362-369.
[13] BLAHUTA J, SOUKUP T, ČERMáK P. The image recognition of brainstem ultrasound images with neural network based on PCA[M]. 2011 I.E. International Symposium on Medical Measurements and Applications (MeMeA 2011) Proceedings Bari: IEEE,2011:134-142.
[14] PLATE A, AHMADI S A, PAULY O, et al.Three dimensional sonographic examination of the midbrain for computer-aided diagnosis of movement disorders[J]. Ultrasound Med Biol,2012,38:2041-2050.
[15] 徐凌丽,李洁,杜俏俏,等.经颅超声检测帕金森病患者中脑黑质强回声定量改变对疾病进展的预测分析[J].中华医学杂志,2018,98(31):2518-2520.
[16] ZECCA L, BERG D, ARZDERGER T, et al.In vivodetection of iron and neuromelanin by transcranial sonography:a new approach for early detection of substantia nigra damage[J]. Mov Disord,2005,20:1278-1285.
[17] 宋馨,张迎春,冯欣宇,等.经颅超声检查帕金森病黑质强回声与铁代谢的相关性[J].中国医学影像学杂志,2021,29(10):968-973.
[18] JESUS-RIBEIRO J, SARGENTO-FREITAS J, SOUSA M, et al.Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson’s disease[J]. Journal of the Neurological Sciences,2016:9-11.
[19] Berg D, Merz B, Reiners K, et al.Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease[J].Mov Disord,2005,20:383-385.
[20] S.BEHNKE, A.RUNKEL, H.A. KASSAR, et al.Long-term course of substantia nigra hyperechogenicity in Parkinson’s disease[J]. Mov Disord,2013,28: 455-459.
[21] WEIS D, LORENZ R, SCHLIESSER M, et al.Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson’s disease[J]. Mov Disord,2009,24: 1669-1675.
[22] BARTOVA P, KRAFT O, BERNATEK J, et al.Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders[J]. Ultrasound Med Biol,2014,40:2365-2371.
[23] BERG D, SIEFKER C, BECKER G.Echogenicity of the substantia nigra in Parkinson’s disease and its relation to clinical findings[J]. J Neurol, 2001,248:684-689.
[24] H-Y.ZHOU. et al. Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease[J]. J Parkinsons Dis,2018,8(2): 333-340.
[25] XIN Y F, YING C Z, CHANG W D, et al.Association Between Asymmetry of Substantia Nigra Hyperechogenicity and Clinical Characteristics in Different Parkinson Disease Subtypes: A 5-Year Follow-up Study[J]. Ultrasound Med Biol,2022,48(10):2139-2145.
[26] 陈鸿旭,王文婷,刘惠苗,等.帕金森病患者黑质高回声与临床特征的关系[J].临床神经病学杂志,2019,32(1):9-12.
[27] 黄梦,延艳娜,张慧,等.经颅超声检查黑质强回声诊断帕金森病的临床价值[J].中西医结合心脑血管病杂志,2022,20(23):4376-4379.
[28] 王晓君,罗蔚锋,王丽君,等.帕金森病患者血尿酸水平[J].中华神经科杂志,2008,41(3):157-158.
[29] 陈星,赵君焱,曹娴,等.帕金森病患者经颅脑超声黑质强回声的临床特征分析[J].中华神经科杂志,2016,49(4):288-293. |
